Targeting the TGFβ signaling network in human neoplasia

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Cell

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1535-6108(03)00135-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

  2003cited by this paper
• Autocrine Transforming Growth Factor-β Signaling Mediates Smad-independent Motility in Human Cancer Cells*

  2003cited by this paper
• Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors

  2003cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

  2002cited by this paper
• Inhibition of Transforming Growth Factor (TGF)- 1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF- Type I Receptor Kinase Activity: SB-431542

  2002cited by this paper
• Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study.

  2002cited by this paper
• Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.

  2002cited by this paper
• Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis

  2002cited by this paper
• Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

  2002cited by this paper
• Soluble Type II Transforming Growth Factor-β (TGF-β) Receptor Inhibits TGF-β Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation

  2001cited by this paper
• Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.

  2001cited by this paper
• Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

  2001cited by this paper
• Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

  2001cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.

  2001cited by this paper
• TGF-β signaling in tumor suppression and cancer progression

  2001cited by this paper
• Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration*

  2000cited by this paper
• Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas

  2000cited by this paper
• Transforming growth factor-β and breast cancer: Tumor promoting effects of transforming growth factor-β

  2000cited by this paper
• Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice

  2000cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000cited by this paper
• Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.

  1999cited by this paper
• Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia.

  1999cited by this paper
• Transforming Growth Factor β1 Is a Target for the von Hippel-Lindau Tumor Suppressor and a Critical Growth Factor for Clear Cell Renal Carcinoma

  1999cited by this paper
• Tumor–host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1

  1999cited by this paper
• The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

  1999cited by this paper
• Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer.

  1999cited by this paper
• A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.

  1999cited by this paper
• Transforming Growth Factor-β and Breast Cancer

  1999cited by this paper
• Smad3 mutant mice develop metastatic colorectal cancer.

  1998cited by this paper
• Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency

  1998cited by this paper
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.

  1998cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor β Receptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen 7,12-Dimethylbenz-[a]-anthracene

  1997cited by this paper
• TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

  1996cited by this paper
• TGFb1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

  1996cited by this paper
• Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

  1995cited by this paper
• TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

  1994cited by this paper
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

  1993cited by this paper
• Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

  1993cited by this paper
• Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.

  1993cited by this paper
• Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.

  1993cited by this paper
• Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice.

  1991cited by this paper
• The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cells

  1988cited by this paper
• Transforming Growth Factor (cid:1) Enhances Epithelial Cell Survival via Akt-dependent Regulation of FKHRL1

  year unknowncited by this paper

• Ethosomes in Integrated Alcoholic Beverages: Unveiling Hidden Dangers and Potential Remedies for Alcoholic Liver Disease.

  2025cites this paper
• Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

  2024cites this paper
• Relationship between gene-environment interaction and obsessive-compulsive disorder: A systematic review.

  2023cites this paper
• Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib.

  2023cites this paper
• Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy

  2022cites this paper
• A Magainin-2 like bacteriocin BpSl14 with anticancer action from fish gut Bacillus safensis SDG14.

  2021cites this paper
• Canonical TGF-β signaling regulates the relationship between prenatal maternal depression and amygdala development in early life

  2021cites this paper
• Effect of Annonaceous Sp. Ethanolic Extract on Transforming Growth Factor- Β (TGF- Β) Expression on MCF-7 Cells Line

  2021cites this paper
• Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications

  2021cites this paper
• The Distinct Roles of Transcriptional Factor KLF11 in Normal Cell Growth Regulation and Cancer as a Mediator of TGF-β Signaling Pathway

  2020cites this paper
• Regulation of breast cancer metastasis signaling by miRNAs

  2020cites this paper
• Structural identification of a fucose-containing 1,3-β-mannoglucan from Poria cocos and its anti-lung cancer CL1-5 cells migration via inhibition of TGFβR-mediated signaling.

  2020cites this paper
• Understanding the Monoclonal Antibody involvement in Targeting the Activation of Tumor Suppressor Genes.

  2020cites this paper
• TGF-β signaling regulates SPOP expression and promotes prostate cancer cell stemness

  2020cites this paper
• Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer

  2020cites this paper
• Multiple actions of parathyroid hormone‐related protein in breast cancer bone metastasis

  2019cites this paper
• A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized Irradiation.

  2019cites this paper
• Current status and future prospects of transforming growth factor‐β as a potential prognostic and therapeutic target in the treatment of breast cancer

  2019cites this paper
• The response of normal tissues to synchrotron microbeam radiotherapy

  2019cites this paper
• In vivo imaging of TGFβ signalling components using positron emission tomography.

  2019cites this paper
• Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

  2018cites this paper
• Protein kinase CK2 activation is required for transforming growth factor β‐induced epithelial–mesenchymal transition

  2018cites this paper
• TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade

  2018cites this paper
• Hsa‐miR‐5582‐3P regulatory effect on TGFβ signaling through targeting of TGFβ‐R1, TGFβ‐R2, SMAD3, and SMAD4 transcripts

  2018cites this paper
• Progress of nanoparticles inhibiting tumor metastasis

  2018cites this paper
• Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation

  2017cites this paper
• Molecular mechanism of Antrodia cinnamomea sulfated polysaccharide on the suppression of lung cancer cell growth and migration via induction of transforming growth factor β receptor degradation.

  2017cites this paper
• Bacteriocins BaCf3 and BpSl14 with anticancer and antibiofilm potential from probiotic Bacillus amyloliquefaciens BTSS3 and Bacillus pumilus SDG14 isolated from gut of marine fishes: Enhanced production, Purification and Characterization

  2017cites this paper
• Transforming growth factor-β: A therapeutic target for cancer

  2017cites this paper
• Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis

  2017cites this paper
• RETRACTED ARTICLE: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells

  2017cites this paper
• Pattern formation in a nonlocal mathematical model for the multiple roles of the TGF-β pathway in tumour dynamics.

  2017cites this paper
• Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran

  2016cites this paper
• Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

  2016cites this paper
• Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma.

  2016cites this paper
• A dual prognostic role for the TGFβ receptors in human breast cancer.

  2016cites this paper
• Imaging TGFβ Signaling in Mouse Models of Cancer Metastasis.

  2016cites this paper
• Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis

  2016cites this paper
• Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.

  2016cites this paper
• Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.

  2015cites this paper
• Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21WAF1 pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells

  2015cites this paper
• Bone metastases in lung cancer. Potential novel approaches to therapy.

  2015cites this paper
• The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies

  2015cites this paper
• RETRACTED ARTICLE: Discovery of a novel inhibitory mechanism of kaempferol on TGF-β ligand-receptor interaction by single-molecule techniques

  2015cites this paper
• Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; in silico and in vitro

  2015cites this paper
• Immunoregulatory effects of Indoleamine 2,3-dioxygenase in Primary Biliary Cirrhosis & Hepatitis C Virus-induced Liver Cirrhosis

  2015cites this paper
• Regulation by a TGFβ-ROCK-actomyosin axis secures a non-linear lumen expansion that is essential for tubulogenesis

  2015cites this paper
• Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer

  2015cites this paper
• Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

  2014cites this paper
• High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer

  2014cites this paper
• Title The Functional Crosstalk between HER 2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy

  2014cites this paper
• Fucoidan inhibition of lung cancer in vivo and in vitro: role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation

  2014cites this paper
• Nonclinical Safety Evaluation of a Transforming Growth Factor β Receptor I Kinase Inhibitor in Fischer 344 Rats and Beagle Dogs

  2014cites this paper
• SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.

  2014cites this paper
• TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes

  2014cites this paper
• Qualitative modeling and analysis of the indoleamine 2,3-dioxygenase regulatory network in homeostasis and disease

  2014cites this paper
• Current and future intratumoral targeted treatment for pancreatic cancer.

  2014cites this paper
• Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype

  2014cites this paper
• Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle

  2013cites this paper
• Rol del factor de crecimiento transformante beta en la progresión del cáncer de pulmón

  2013cites this paper
• The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T Cells

  2013cites this paper
• Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.

  2013influential citation
• HtrA3 is negatively correlated with lymph node metastasis in invasive ductal breast cancer

  2013cites this paper
• An Integrated Human Mammary Epithelial Cell Culture System for Studying Carcinogenesis and Aging

  2013cites this paper
• Strong Impact of TGF-β1 Gene Polymorphisms on Breast Cancer Risk in Indian Women: A Case-Control and Population-Based Study

  2013cites this paper
• Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion

  2013cites this paper
• Regulation of tumor cell dormancy by tissue microenvironments and autophagy.

  2013cites this paper
• Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.

  2013cites this paper
• Combined effects of differentiation factor 15 and substance use of alcohol, betel quid and cigarette on risk of head and neck cancer

  2013cites this paper
• The Th17 Pathway as a Therapeutic Target in Rheumatoid Arthritis and Other Autoimmune and Inflammatory Disorders

  2013cites this paper
• Direct inhibition of the transforming growth factor‐β pathway by protein‐bound polysaccharide through inactivation of Smad2 signaling

  2012cites this paper
• Microenvironments dictating tumor cell dormancy.

  2012cites this paper
• Efficacy and Mechanistic Evaluation of Tic10, A Novel Antitumor Agent

  2012cites this paper
• TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer

  2012cites this paper
• Human Dendritic Cells in Cancer

  2012cites this paper
• The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis

  2012cites this paper
• Nuclear Translocation of Type I Transforming Growth Factor β Receptor Confers a Novel Function in RNA Processing

  2012cites this paper
• The H6D variant of NAG‐1/GDF15 inhibits prostate xenograft growth in vivo

  2012cites this paper
• Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression

  2012cites this paper
• The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy

  2011cites this paper
• A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-β ligand-receptor binding.

  2011cites this paper
• The Role of Activin in Mammary Gland Development and Oncogenesis

  2011cites this paper
• Role of TLR2‐dependent inflammation in metastatic progression

  2011cites this paper
• Validation of Growth Differentiation Factor (GDF-15) as a Radiation Response Gene and Radiosensitizing Target in Mammary Adenocarcinoma Model

  2011cites this paper
• The Mesenchymal-Like Phenotype of the MDA-MB-231 Cell Line

  2011cites this paper
• The role of platelet-derived growth factor in radiation injury to the lower urinary tract

  2011cites this paper
• Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.

  2011cites this paper
• Development of Tumor-Infiltrating CD8+ T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-β Blockade during the Perioperative Period of Tumor Resection

  2011cites this paper
• Crosstalk of the Wnt Signaling Pathway

  2011cites this paper
• Molecular classification of breast cancer

  2011cites this paper
• When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

  2011cites this paper
• A Functional Study of Transforming Growth Factor-Beta from the Gonad of Pacific Oyster Crassostrea gigas

  2011cites this paper
• Targeting the Wnt pathway in cancer

  2011cites this paper
• Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines.

  2011cites this paper
• Stromal regulation of vessel stability by MMP14 and TGFβ

  2010cites this paper
• Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM

  2010cites this paper
• HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.

  2010cites this paper
• Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Myelofibrosid (CIMF), Myelofibrosis with Myeloid Metaplasia (MMM), Agnogenic Myeloid Metaplasia (AMM)]

  2010cites this paper
• TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.

  2010cites this paper
• HtrA proteins as targets in therapy of cancer and other diseases

  2010cites this paper